TS
KYNB

Thomas Steyer’s Kyntra Bio KYNB Stock Holding History

Thomas Steyer’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,591
Closed -$4.38M – 321
2022
Q1 		$4.38M Sell
14,591
-22,174
-60% -$7.73M 0.02% 193
2021
Q4 		$13M Sell
36,765
-21,083
-36% -$6.56M 0.06% 115
2021
Q3 		$14.8M Buy
57,848
+291
+0.5% +$103K 0.07% 118
2021
Q2 		$38.3M Sell
57,557
-9,791
-15% -$5.64M 0.16% 81
2021
Q1 		$58.4M Sell
67,348
-8,652
-11% -$9.21M 0.29% 65
2020
Q4 		$70.5M Buy
76,000
+2,000
+3% +$2.1M 0.42% 57
2020
Q3 		$76.1M Buy
74,000
+9,000
+14% +$9.68M 0.53% 51
2020
Q2 		$65.9M Buy
65,000
+1,013
+2% +$941K 0.53% 49
2020
Q1 		$55.6M Buy
63,987
+9,987
+18% +$9.93M 0.48% 40
2019
Q4 		$57.9M Buy
54,000
+14,000
+35% +$14.3M 0.39% 51
2019
Q3 		$37M Sell
40,000
-28,000
-41% -$30.8M 0.28% 54
2019
Q2 		$76.8M Buy
68,000
+31,377
+86% +$34.3M 0.5% 46
2019
Q1 		$49.8M Buy
36,623
+6,623
+22% +$8.98M 0.37% 52
2018
Q4 		$34.7M Sell
30,000
-25,800
-46% -$29M 0.25% 56
2018
Q3 		$84.7M Sell
55,800
-12,900
-19% -$19.9M 0.5% 38
2018
Q2 		$108M Hold
68,700
– – 0.66% 34
2018
Q1 		$79.3M Buy
68,700
+2,400
+4% +$3.16M 0.55% 38
2017
Q4 		$78.6M Buy
66,300
+22,300
+51% +$28M 0.64% 33
2017
Q3 		$59.2M Buy
44,000
+1,120
+3% +$1.18M 0.53% 44
2017
Q2 		$34.6M Buy
42,880
+15,600
+57% +$10.9M 0.36% 46
2017
Q1 		$16.8M Sell
27,280
-4,000
-13% -$2.44M 0.18% 56
2016
Q4 		$16.7M Buy
31,280
+22,280
+248% +$11.1M 0.19% 48
2016
Q3 		$4.66M Buy
+9,000
New +$4.24M 0.07% 58

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Thomas Steyer's KYNB Position: Q2 2022 in Review

Thomas Steyer sold out of Kyntra Bio (KYNB) in Q2 2022, closing a stake of 14,591 shares — an estimated $4.38M sold.

Thomas Steyer first reported a position in KYNB in Q3 2016 and held it in 23 quarters. The position peaked at $108M in Q2 2018. 150 funds tracked by Wall St. Rank hold KYNB as of Q2 2022.

  • Thomas Steyer reported no remaining Kyntra Bio position as of Q2 2022 after selling out during the quarter.
  • Thomas Steyer sold 14,591 Kyntra Bio shares in Q2 2022, an estimated $4.38M.
  • Thomas Steyer first reported a position in Kyntra Bio in Q3 2016 and held it in 23 quarters.
  • Thomas Steyer's Kyntra Bio position peaked at $108M in Q2 2018.
  • 150 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2022.

Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.